Dr. Mohammad Yaqoob Wani
Loading…
Loading…
Interventional Oncology & Minimally Invasive Liver Cancer Care
Targeted endovascular cancer therapy delivering high-concentration chemotherapy directly to liver tumours followed by arterial embolization to starve cancer cells while preserving healthy liver tissue.
Understanding the procedure, clinical intent, and target benefits.
Transarterial chemoembolization is a minimally invasive, catheter-based treatment used primarily for hepatocellular carcinoma (HCC), the most common form of primary liver cancer, as well as select metastatic liver malignancies. Unlike conventional intravenous chemotherapy which circulates throughout the entire body and causes widespread systemic toxicity, TACE delivers cytotoxic medication directly inside the liver tumour.
The foundation of TACE relies on the liver's distinct dual circulatory system. Normal liver hepatocytes receive approximately 75% to 80% of their nutrient and blood supply from the portal vein and only 20% to 25% from the hepatic artery. In contrast, liver cancers and hypervascular metastases depend almost exclusively (>90%) on branches of the hepatic artery for their survival and expansion.
By navigating a specialized microcatheter into the tumour-feeding arterial branches, high-dose chemotherapy is deposited directly within the lesion, immediately followed by embolic agents that halt blood supply. This dual mechanism induces profound tumour starvation, cellular hypoxia, and ischemic necrosis while preserving surrounding non-tumorous liver parenchyma.
Two globally established approaches are offered based on clinical presentation: Conventional TACE (cTACE), where chemotherapy is mixed with Lipiodol (an oily contrast medium selectively absorbed and retained by malignant liver cells) followed by embolic particles, and Drug-Eluting Bead TACE (DEB-TACE), which utilizes precisely calibrated microspheres that concurrently occlude tumour vessels and deliver sustained local chemotherapy over several days.
جگر کے کینسر (HCC) اور کینسر کی رسولیوں کو خون پہنچانے والی شریانوں میں کلائی یا ران کے ذریعے باریک کیتھیٹر داخل کر کے براہِ راست کیموتھراپی دی جاتی ہے اور خون کی روانی بند (Embolization) کر کے رسولی کو اندر سے سکھا دیا جاتا ہے، جس سے صحت مند جگر محفوظ رہتا ہے۔
This procedure is commonly indicated or evaluated for patients experiencing:
Traditional surgery requires large cuts to visualize organs. Interventional radiology uses the body's natural blood vessels as internal highways, treating issues from within.
Procedure Journey
A step-by-step look at the patient experience from access to discharge.
Prior to treatment, detailed staging is performed with triple-phase CT or dynamic contrast-enhanced MRI to map tumour size, vascularity, and number. Liver functional reserve is confirmed using Child-Pugh and MELD scoring systems, alongside baseline LFTs, renal function, coagulation profile (PT/INR), and serum alpha-fetoprotein (AFP).
The procedure is carried out in the advanced digital angiography suite under local anaesthesia with mild conscious sedation. A pinhole puncture is made into the femoral artery in the groin or the radial artery at the wrist, and a slender vascular sheath (2mm) is positioned without surgical incisions or sutures.
Under continuous real-time fluoroscopic guidance, a specialized diagnostic catheter is navigated through the aorta into the celiac trunk and hepatic arterial system. Contrast angiography maps the unique vascular anatomy and confirms the precise arterial supply feeding the liver tumours.
A hair-thin, highly flexible microcatheter is advanced superselectively into the terminal subsegmental arterial branches feeding the tumour. This extreme precision isolates the malignancy and protects surrounding healthy hepatic parenchyma from chemotherapy exposure.
Chemotherapy is delivered directly into the tumour bed. Depending on clinical criteria, either Conventional TACE (cTACE with an emulsion of chemotherapeutic agent and Lipiodol oily contrast) or Drug-Eluting Bead TACE (DEB-TACE with specialized drug-loaded microspheres) is administered, followed by embolic particles (PVA or microspheres) that completely block tumor blood flow, trapping the cytotoxic agent and inducing ischemic necrosis.
Post-embolization angiograms verify complete cessation of tumour arterial flow. The microcatheter and access sheath are removed, and the tiny puncture site is sealed with compression or a closure device. The patient is observed in the recovery unit for 12–24 hours and is typically discharged home the following day.
Why catheter-guided procedures are the preferred modern option.
Clinical Outcomes
Proven outcomes and functional recovery benefits for eligible patients.
Transarterial Chemoembolization provides distinct therapeutic benefits over conventional chemotherapy and invasive surgery for liver tumours.
FAQs
Clinical Philosophy
Delivering advanced minimally invasive solutions for neurological, vascular, oncological and musculoskeletal disorders.
Expertise in Neurointervention and Advanced Endovascular Therapies for complex vascular conditions.
Comprehensive Brain, Stroke and Aneurysm Care with 24x7 emergency rapid response.
Specialized Thyroid Ablation and Embolization Services, offering scarless alternatives to surgery.
Advanced Peripheral Vascular and Limb Salvage Procedures to heal diabetic foot ulcers and prevent amputation.
Interventional Oncology and Tumor Ablation Expertise for targeted, precise cancer treatments.
Comprehensive Pain, Spine and Musculoskeletal Interventions to rapidly restore mobility and comfort.
Cutting-Edge Minimally Invasive Treatment Options performed through tiny pinholes instead of open surgery.
Personalized, Evidence-Based Patient Care designed around your specific diagnosis and lifestyle.
Get expert clinical assessment at Medicare Super Speciality Hospital, Srinagar. Discuss whether a minimally invasive catheter procedure is the right path for your recovery.